» Articles » PMID: 39057044

The Potential MicroRNA Diagnostic Biomarkers in Oral Squamous Cell Carcinoma of the Tongue

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2024 Jul 26
PMID 39057044
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) of the tongue is a common type of head and neck malignancy with a poor prognosis, underscoring the urgency for early detection. MicroRNAs (miRNAs) have remarkable stability and are easily measurable. Thus, miRNAs may be a promising biomarker candidate among biomarkers in cancer diagnosis. Biomarkers have the potential to facilitate personalized medicine approaches by guiding treatment decisions and optimizing therapy regimens for individual patients. Utilizing data from The Cancer Genome Atlas, we identified 13 differentially expressed upregulated miRNAs in OSCC of the tongue. Differentially expressed miRNAs were analyzed by enrichment analysis to reveal underlying biological processes, pathways, or functions. Furthermore, we identified miRNAs associated with the progression of OSCC of the tongue, utilizing receiver operating characteristic analysis to evaluate their potential as diagnostic biomarkers. A total of 13 upregulated miRNAs were identified as differentially expressed in OSCC of the tongue. Five of these miRNAs had high diagnostic power. In particular, miR-196b has the potential to serve as one of the most effective diagnostic biomarkers. Then, functional enrichment analysis for the target gene of miR-196b was performed, and a protein-protein interaction network was constructed. This study assessed an effective approach for identifying miRNAs as early diagnostic markers for OSCC of the tongue.

Citing Articles

Oral Cancer: Prophylaxis, Etiopathogenesis and Treatment.

Popovici V, Ozon E Curr Issues Mol Biol. 2024; 46(11):12911-12913.

PMID: 39590362 PMC: 11592552. DOI: 10.3390/cimb46110768.

References
1.
Lu Y, Chang J, Huang Y, Huang C, Chen W, Lee L . Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem. 2014; 48(3):115-21. DOI: 10.1016/j.clinbiochem.2014.11.020. View

2.
Youle R, Narendra D . Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2010; 12(1):9-14. PMC: 4780047. DOI: 10.1038/nrm3028. View

3.
Kalia M . Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2014; 64(3 Suppl 1):S16-21. DOI: 10.1016/j.metabol.2014.10.027. View

4.
Rodini C, Xavier F, Paiva K, de Souza Setubal Destro M, Moyses R, Michaluarte P . Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma. Int J Oncol. 2012; 40(4):1180-8. PMC: 3584618. DOI: 10.3892/ijo.2011.1321. View

5.
Almangush A, Heikkinen I, Makitie A, Coletta R, Laara E, Leivo I . Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer. 2017; 117(6):856-866. PMC: 5589992. DOI: 10.1038/bjc.2017.244. View